Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.
about
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.Functional Properties of Human Stem Cell-Derived Neurons in Health and DiseaseEmerging Link between Alzheimer's Disease and Homeostatic Synaptic PlasticityImplications of GABAergic Neurotransmission in Alzheimer's DiseaseDissecting Alzheimer disease in Down syndrome using mouse modelsGene expression parallels synaptic excitability and plasticity changes in Alzheimer's diseaseMicrocircuits and their interactions in epilepsy: is the focus out of focus?Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's diseaseCortical odor processing in health and diseaseIssues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsyEntorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age.Nuclear pore complex remodeling by p75(NTR) cleavage controls TGF-β signaling and astrocyte functionsInhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus.Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer's disease model.Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathologyIntegrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stageThe dendritic hypothesis for Alzheimer's disease pathophysiology.Ion channels in genetic and acquired forms of epilepsy.Interneuron Progenitor Transplantation to Treat CNS DysfunctionHippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planningHippocampal-prefrontal circuit and disrupted functional connectivity in psychiatric and neurodegenerative disordersStem cell therapy for Alzheimer's disease and related disorders: current status and future perspectivesElevated serum pesticide levels and risk for Alzheimer diseaseNa, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.Ovariectomy and subsequent treatment with estrogen receptor agonists tune the innate immune system of the hippocampus in middle-aged female ratsSelective spider toxins reveal a role for the Nav1.1 channel in mechanical painSepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice.Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice.Deletion of KCC3 in parvalbumin neurons leads to locomotor deficit in a conditional mouse model of peripheral neuropathy associated with agenesis of the corpus callosumNitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.Trajectory of the main GABAergic interneuron populations from early development to old age in the rat primary auditory cortex.Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-βGABA progenitors grafted into the adult epileptic brain control seizures and abnormal behaviorLamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model.Seizures and epileptiform activity in the early stages of Alzheimer diseaseReducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer's disease.Limited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's disease.Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.
P2860
Q24624879-D65AEF3F-40A8-487D-AC07-E352094AF925Q26747622-7EF1C29B-34AE-4205-88F1-5F8F140D1768Q26750576-67C06192-D772-461A-835E-89476488E5C2Q26768593-0CA78BAB-FE40-4494-A54A-45E46789E3BEQ26777254-3855B46F-F1C1-4203-8F25-D2BAB6049E29Q26785375-9E41E6B4-A275-4FA3-A36E-09F2E7844C91Q26861458-07D22C9B-7071-4B51-85A4-0936B78915B2Q27024122-250285CA-413D-4726-944E-3B2783ED2AB9Q27024894-01152734-5A1C-4ED2-8C24-0912129BD73FQ27026690-1911ADE9-B377-408F-AD78-9E4559B56882Q27307826-E9886111-2822-4CD7-BF53-5860E51F3799Q27312233-29473C5A-0C57-42A4-A2CD-AB676075BE73Q27313143-F51AF66E-865A-478A-B8E0-117441F51B2EQ27316651-2E26376B-6C94-41EA-8554-770BADE609E3Q27438189-4ECACDE7-A3DB-47F7-8BCF-2C84765232BAQ27500371-D57E0BA3-EE29-4D86-A74F-9ED7AC2DED78Q27687404-6A0F3F1D-FAB2-48E0-A217-C1C77BD8F6F0Q27693827-C588A8BE-9438-470D-B847-7327D135CF85Q28077603-F189FACD-F01E-45DA-85F4-DA34FC92DDE2Q28083958-FD1B6DD5-A9ED-43E7-A455-E3C8C1FC29FBQ28084481-114C4067-4720-49D4-B89A-FDDAAD9026FAQ28085612-45C0FB73-C5C4-4095-A060-2EE05E0DB841Q28392325-1FD916DD-214D-4933-9898-A0CF4E88A767Q28572007-6F595C14-99AE-49EA-9F96-1D1A98233824Q28573502-1A0FE2B6-B1B0-4944-9D57-F26C88F32F17Q28594552-450742A1-1358-42D7-9176-9199063334E1Q30278606-5921A527-8989-4820-B248-8310EC0A6CB6Q30357529-D89AED87-814F-45CF-A408-3D4A9CE60F3DQ30374432-8F1D1845-BEE3-4EC6-A8A6-A856A1DE99C9Q30399713-99930CCC-7ADD-4026-A986-06CD54E190A9Q30431810-658F52A5-BC44-4643-9F3B-4598EF5E5DA3Q30436933-3157315F-F3BD-415A-8F26-E25537C0659BQ30444295-2C5510CC-6E35-4DFF-854E-978B0DBA3DE4Q30539255-BAE2577F-7078-4C18-80A7-E18979C5D953Q30540112-60455C0E-A370-4D65-9008-9A8DC9505331Q30540206-08375366-1D5A-4B66-BF0E-57D92A5845B3Q30577633-2D199489-0CDB-4D49-AFF4-FCDA111AA431Q30586616-51C97D30-B81D-40A7-9B49-0901C74E5A79Q30637868-4B4D3199-0786-41DF-85FA-D6759BF3BBFBQ30640315-ACFA231B-B51D-44BE-A73A-021D95CE1C51
P2860
Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Inhibitory interneuron deficit ...... dysfunction in Alzheimer model
@nl
Inhibitory interneuron deficit ...... ysfunction in Alzheimer model.
@ast
Inhibitory interneuron deficit ...... ysfunction in Alzheimer model.
@en
type
label
Inhibitory interneuron deficit ...... dysfunction in Alzheimer model
@nl
Inhibitory interneuron deficit ...... ysfunction in Alzheimer model.
@ast
Inhibitory interneuron deficit ...... ysfunction in Alzheimer model.
@en
prefLabel
Inhibitory interneuron deficit ...... dysfunction in Alzheimer model
@nl
Inhibitory interneuron deficit ...... ysfunction in Alzheimer model.
@ast
Inhibitory interneuron deficit ...... ysfunction in Alzheimer model.
@en
P2093
P2860
P50
P3181
P1433
P1476
Inhibitory interneuron deficit ...... ysfunction in Alzheimer model.
@en
P2093
Albert M I Barth
Anatol C Kreitzer
Giao B Hang
Inma Cobos
Istvan Mody
Jorge J Palop
Kaitlyn Ho
Lennart Mucke
Nino Devidze
P2860
P304
P3181
P356
10.1016/J.CELL.2012.02.046
P407
P577
2012-04-01T00:00:00Z